List of Apriso drug patents
Apriso is owned by Valeant Pharms Intl.
Apriso contains Mesalamine.
Apriso has a total of 1 drug patent out of which 0 drug patents have expired.
Apriso was authorised for market use on 31 October, 2008.
Apriso is available in capsule, extended release;oral dosage forms.
Apriso can be used as for the maintenance of remission of ulcerative colitis.
The generics of Apriso are possible to be released after 01 May, 2030.
| Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US8865688 | VALEANT PHARMS INTL | Compositions and methods for treatment of bowel diseases with granulated mesalamine |
May, 2030
(7 years from now) | |
Drugs and Companies using MESALAMINE ingredient
Market Authorisation Date: 31 October, 2008
Treatment: For the maintenance of remission of ulcerative colitis
Dosage: CAPSULE, EXTENDED RELEASE;ORAL
availability in other generic markets.
Click on the highlighted region to filter.
900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight
Join them to stay ahead in capturing the next drug going generic